{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470610761
| IUPAC_name = (16Î±)-21-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]-16-methylpregna-1,4,9(11)-triene-3,20-dione
| image = Tirilazad.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 110101-66-1
| ATC_prefix = N07
| ATC_suffix = XX01
| PubChem = 104903
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 94673
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = YD064E883I
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08606
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1630578

<!--Chemical data-->
| C=38 | H=52 | N=6 | O=2 
| molecular_weight = 624.859 g/mol
| smiles = O=C(CN4CCN(c2nc(nc(N1CCCC1)c2)N3CCCC3)CC4)[C@H]6[C@H](C)C[C@H]5[C@H]8C(=C/C[C@@]56C)\[C@]/7(/C=C\C(=O)\C=C\7CC8)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C38H52N6O2/c1-26-22-31-29-9-8-27-23-28(45)10-12-37(27,2)30(29)11-13-38(31,3)35(26)32(46)25-41-18-20-43(21-19-41)34-24-33(42-14-4-5-15-42)39-36(40-34)44-16-6-7-17-44/h10-12,23-24,26,29,31,35H,4-9,13-22,25H2,1-3H3/t26-,29-,31+,35-,37+,38+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RBKASMJPSJDQKY-RBFSKHHSSA-N
| synonyms = <small>(8''S'',10''S'',13''S'',14''S'',16''R'',17''S'')-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[''a'']phenanthren-3-one</small>
}}

'''Tirilazad''' is a drug that has been proposed to treat acute ischaemic [[stroke]]. When tested on animal models, tirilazad protects brain tissue, and reduces brain damage. However, the drug fails to treat, and even worsens a stroke when studied on a human being.<ref>{{cite web |url=http://www.cochrane.org/reviews/en/ab002087.html |title=Tirilazad for acute ischaemic stroke |accessdate=2007-07-28 |format= |work=}}</ref>

== Usage in treatment of stroke ==
Tirilazad currently has no usage in the clinical treatment of stroke.

==References==
{{reflist}}

{{Other nervous system drugs}}
{{Piperazines}}

[[Category:Piperazines]]
[[Category:Pregnanes]]
[[Category:Pyrimidines]]
[[Category:Pyrrolidines]]

{{nervous-system-drug-stub}}